gemcitabine hydrochloride

Product NDC
45963-612
11-digit product format
459630612
Labeler code
45963
Product ID
45963-612_f7af83fb-a439-4d8b-ba1a-fddbd803642c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
gemcitabine hydrochloride
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Labeler
Actavis Pharma, Inc.
Application
ANDA079160
Marketing category
ANDA
Marketing start
2015-02-02
Marketing end
2020-10-31
Substance
GEMCITABINE HYDROCHLORIDE
Active strength
200 mg/5mL
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
45963-612-57EA - Each45963-61203b4ffad-5004-4039-a499-f536ffa443b012015-02-02